The SN38 was incorporated into a polymeric conjugate capable of self-assembly into nanoparticles, which not only reduced the toxicity of the drug, but also improved its ability to activate the cGAS-STING pathway and induce strong antitumor immune responses in an in vivo murine model of breast cancer. The gene discussed is STING1; the disease is breast cancer.